CD8A and neoplasm: Tumors with high TMB offer a more immunogenic tumor microenvironment with more tumor neoantigens and increased CD8-positive and PD-1-positive T-cell infiltration, which may increase the vulnerability of tumor cells to the immune-related effects of radiotherapy (21, 24).